These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38035530)

  • 21. Generation of heterozygous (MRli003-A-3) and homozygous (MRli003-A-4) TRPM4 knockout human iPSC lines.
    Zhang F; Meier AB; Lipp P; Laugwitz KL; Dorn T; Moretti A
    Stem Cell Res; 2022 Apr; 60():102731. PubMed ID: 35245852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of a homozygous RANGRF knockout hiPSC line by CRISPR/Cas9 system.
    Jiang M; Tang C; Luo X; Zhou X; Chen M; Chi Y; Lai L; Zou Q
    Stem Cell Res; 2023 Sep; 71():103136. PubMed ID: 37327621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of homozygous Na
    Maurer W; Hartmann N; Argyriou L; Sossalla S; Streckfuss-Bömeke K
    Stem Cell Res; 2022 Apr; 60():102677. PubMed ID: 35092938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of human induced pluripotent stem cell line carrying SCN5AC2204>T Brugada mutation (MUSli009-A-1) introduced by CRISPR/Cas9-mediated genome editing.
    Angsutararux P; Luanpitpong S; Chingsuwanrote P; Supraditaporn K; Waeteekul S; Terbto P; Lorthongpanich C; Laowtammathron C; U-Pratya Y; Issaragrisil S
    Stem Cell Res; 2019 Dec; 41():101618. PubMed ID: 31677524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of homozygous and heterozygous REEP1 knockout induced pluripotent stem cell lines by CRISPR/Cas9 gene editing.
    Korneck M; Leonhardt A; Schöls L; Hauser S
    Stem Cell Res; 2024 Jun; 77():103378. PubMed ID: 38479332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of RUNX1c-eGFP induced pluripotent stem cell, MUSIi012-A-4, using CRISPR/Cas9.
    Srisook P; Laowtammathron C; Lorthongpanich C; Klaihmon P; Terbto P; Waeteekul S; U-Pratya Y; Issaragrisil S
    Stem Cell Res; 2023 Mar; 67():103035. PubMed ID: 36753833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of an NCS1 gene knockout human induced pluripotent stem cell line using CRISPR/Cas9.
    Maierhof SK; Schinke C; Cernoch J; Hew L; Bruske LP; Fernandez Vallone V; Fischer K; Stachelscheid H; Huehnchen P; Endres M; Diecke S; Telugu NS; Boehmerle W
    Stem Cell Res; 2023 Dec; 73():103253. PubMed ID: 37984032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Derivation of induced pluripotent stem cells line (RCPCMi007-A-1) with inactivation of the beta-2-microglobulin gene by CRISPR/Cas9 genome editing.
    Bogomiakova ME; Sekretova EK; Eremeev AV; Shuvalova LD; Bobrovsky PA; Zerkalenkova EA; Lebedeva OS; Lagarkova MA
    Stem Cell Res; 2021 Aug; 55():102451. PubMed ID: 34237591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of a KSCBi005-A-5(TLR8KO-A10) homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9.
    Han HJ; Han HW; Seo HH; Kim JH
    Stem Cell Res; 2019 Oct; 40():101561. PubMed ID: 31526944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of CRISPR-Cas9 edited human induced pluripotent stem cell line carrying FLNC exon skipping variant.
    Ader F; Duboscq-Bidot L; Marteau S; Hamlin M; Richard P; Fontaine V; Villard E
    Stem Cell Res; 2022 Jan; 58():102616. PubMed ID: 34883448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of two LRRK2 homozygous knockout human induced pluripotent stem cell lines using CRISPR/Cas9.
    Chen S; Luo Z; Ward C; Ibañez DP; Liu H; Zhong X; Sharma NK; Qin B; Fan W; Wang D
    Stem Cell Res; 2020 May; 45():101804. PubMed ID: 32339904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of a gene-corrected human isogenic line (UAMi006-A) from propionic acidemia patient iPSC with an homozygous mutation in the PCCB gene using CRISPR/Cas9 technology.
    Fulgencio-Covián A; Álvarez M; Pepers BA; López-Márquez A; Ugarte M; Pérez B; van Roon-Mom WMC; Desviat LR; Richard E
    Stem Cell Res; 2020 Dec; 49():102055. PubMed ID: 33128956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of a human induced pluripotent stem cell line carrying the TYR c.575C>A (p.Ser192Tyr) and c.1205G>A (p.Arg402Gln) variants in homozygous state using CRISPR-Cas9 genome editing.
    Liu J; Black GC; Kimber SJ; Sergouniotis PI
    Stem Cell Res; 2022 Oct; 64():102880. PubMed ID: 35933957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modeling of dilated cardiomyopathy by establishment of isogenic human iPSC lines carrying phospholamban C25T (R9C) mutation (UPITTi002-A-1) using CRISPR/Cas9 editing.
    Barndt RJ; Ma N; Tang Y; Haugh MP; Alamri LS; Chan SY; Wu H
    Stem Cell Res; 2021 Oct; 56():102544. PubMed ID: 34583280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of a human Neurochondrin deficient iPSC line KICRi002-A-3 using CRISPR/Cas9.
    Fatima A; Schuster J; Akram T; Sobol M; Hoeber J; Dahl N
    Stem Cell Res; 2020 Apr; 44():101758. PubMed ID: 32203915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRISPR/Cas9-mediated editing of ACTB in induced pluripotent stem cells: A model for investigating human ACTB loss-of-function and genetic adaptive responses.
    Binder S; Ramachandran H; Haslinger D; Hildebrandt B; Dobner J; Haarmann-Stemmann T; Chiocchetti A; Rossi A
    Stem Cell Res; 2024 Jun; 77():103395. PubMed ID: 38518401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Derivation of human pluripotent stem cell line via CRISPR/Cas9 mediated deletion of exon 3 LAMA2 gene (DMBi001-A-1).
    Jelinkova S; Martyniak A; Dulak J; Stępniewski J
    Stem Cell Res; 2021 Oct; 56():102529. PubMed ID: 34509921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of a MIR5004 knockout cell line from human induced pluripotent stem cells by CRISPR/Cas9 gene editing.
    Gulimiheranmu M; Li S; Zhou J
    Stem Cell Res; 2022 Jul; 62():102805. PubMed ID: 35576811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of a SOX9-tdTomato reporter human iPSC line, MCRIi001-A-2, using CRISPR/Cas9 editing.
    Nur Patria Y; Lilianty J; Elefanty AG; Stanley EG; Labonne T; Bateman JF; Lamandé SR
    Stem Cell Res; 2020 Jan; 42():101689. PubMed ID: 31884373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9.
    Paquet D; Kwart D; Chen A; Sproul A; Jacob S; Teo S; Olsen KM; Gregg A; Noggle S; Tessier-Lavigne M
    Nature; 2016 May; 533(7601):125-9. PubMed ID: 27120160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.